• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化患者呼吸道感染治疗中的临床与经济选择:医院护理与家庭护理对比

Clinical and economic choices in the treatment of respiratory infections in cystic fibrosis: comparing hospital and home care.

作者信息

Thornton J, Elliott R A, Tully M P, Dodd M, Webb A K

机构信息

School of Pharmacy and Pharmaceutical Sciences, University of Manchester M13 9PL, UK.

出版信息

J Cyst Fibros. 2005 Dec;4(4):239-47. doi: 10.1016/j.jcf.2005.08.003. Epub 2005 Oct 19.

DOI:10.1016/j.jcf.2005.08.003
PMID:16242385
Abstract

BACKGROUND

A cost-effectiveness evaluation comparing home-based and hospital-based treatment with intravenous antibiotics for respiratory exacerbations in adults with cystic fibrosis (CF) has not been previously undertaken.

METHODS

The study was conducted in a UK adult CF centre from a health service perspective. Clinical outcome and resource use data were obtained from a retrospective one-year study and combined with unit cost data in an incremental economic analysis. The primary outcome measure was percentage change in FEV(1); "effectiveness" was defined as maintenance of baseline average FEV(1) over the one-year study period.

RESULTS

116 patients received 454 courses of intravenous antibiotics. At the end of 1 year, there had been a mean percentage decline in FEV(1) compared with baseline average for home-treated patients but an improvement for hospital-treated patients (Tukey's HSD mean difference 10.1%, 95% CI 2.9 to 17.2, p = 0.003). Treatment was deemed "effective" in more hospital (58.8%) than home (42.6%) patients. The cost of hospital treatment was higher than home treatment (mean difference 9,005 pounds, 95% CI 3,507 to 14,700, p<0.001). The mean ICER was 46,098 pounds (2.5th and 97.5th percentiles -374,044 and 362,472).

CONCLUSIONS

Hospital treatment was more effective but more expensive than home treatment. Potential methods to improve outcome at home should be considered but these may have resource implications.

摘要

背景

此前尚未对成年囊性纤维化(CF)患者因呼吸道疾病加重采用家庭静脉抗生素治疗和医院静脉抗生素治疗进行成本效益评估。

方法

本研究从卫生服务角度在英国一家成人CF中心开展。临床结局和资源使用数据来自一项为期一年的回顾性研究,并在增量经济分析中与单位成本数据相结合。主要结局指标是第一秒用力呼气容积(FEV₁)的百分比变化;“有效性”定义为在为期一年的研究期间维持基线平均FEV₁。

结果

116例患者接受了454个疗程的静脉抗生素治疗。1年后,与基线平均值相比,家庭治疗患者的FEV₁平均百分比下降,但医院治疗患者有所改善(Tukey's HSD平均差异10.1%,95%CI 2.9至17.2,p = 0.003)。认为治疗“有效”的医院患者(58.8%)多于家庭患者(42.6%)。医院治疗的成本高于家庭治疗(平均差异9005英镑,95%CI 3507至14700,p<0.001)。平均增量成本效果比为46098英镑(第2.5和第97.5百分位数为-374044和362472)。

结论

医院治疗比家庭治疗更有效,但成本更高。应考虑在家中改善结局的潜在方法,但这些方法可能会对资源产生影响。

相似文献

1
Clinical and economic choices in the treatment of respiratory infections in cystic fibrosis: comparing hospital and home care.囊性纤维化患者呼吸道感染治疗中的临床与经济选择:医院护理与家庭护理对比
J Cyst Fibros. 2005 Dec;4(4):239-47. doi: 10.1016/j.jcf.2005.08.003. Epub 2005 Oct 19.
2
Comparing costs of home- versus hospital-based treatment of infections in adults in a specialist cystic fibrosis center.比较在一家专科囊性纤维化中心对成人感染进行家庭治疗与医院治疗的成本。
Int J Technol Assess Health Care. 2005 Fall;21(4):506-10. doi: 10.1017/S0266462305050701.
3
Long term clinical outcome of home and hospital intravenous antibiotic treatment in adults with cystic fibrosis.成年囊性纤维化患者家庭与医院静脉注射抗生素治疗的长期临床结果
Thorax. 2004 Mar;59(3):242-6. doi: 10.1136/thx.2003.005876.
4
Effectiveness of home treatment for patients with cystic fibrosis: the intravenous administration of antibiotics to treat respiratory infections.囊性纤维化患者家庭治疗的有效性:静脉注射抗生素治疗呼吸道感染。
Pediatr Pulmonol. 2008 Sep;43(9):908-15. doi: 10.1002/ppul.20878.
5
Home versus hospital intravenous antibiotic therapy for acute pulmonary exacerbations in children with cystic fibrosis.囊性纤维化患儿急性肺部加重期在家与在医院进行静脉抗生素治疗的比较。
Pediatr Pulmonol. 2006 Aug;41(8):744-9. doi: 10.1002/ppul.20433.
6
Comparison of hospital and home intravenous antibiotic therapy in adults with cystic fibrosis.成人囊性纤维化患者住院与居家静脉注射抗生素治疗的比较。
J Clin Nurs. 2006 Jan;15(1):52-60. doi: 10.1111/j.1365-2702.2005.01236.x.
7
Location and duration of treatment of cystic fibrosis respiratory exacerbations do not affect outcomes.囊性纤维化呼吸加重症的治疗位置和持续时间并不影响治疗结果。
Am J Respir Crit Care Med. 2010 Nov 1;182(9):1137-43. doi: 10.1164/rccm.201001-0057OC. Epub 2010 Jun 25.
8
Home and hospital antibiotic treatment prove similarly effective in cystic fibrosis.家庭和医院抗生素治疗在囊性纤维化中同样有效。
Infection. 2002 Dec;30(6):387-91. doi: 10.1007/s15010-002-2095-0.
9
Cost of home and hospital care for patients with cystic fibrosis followed up in two reference medical centers in France.在法国两个参考医疗中心对囊性纤维化患者进行家庭和医院护理的费用。
Int J Technol Assess Health Care. 2006 Fall;22(4):525-31. doi: 10.1017/S0266462306051476.
10
Effectiveness of home versus hospital care in the routine treatment of cystic fibrosis.家庭护理与医院护理在囊性纤维化常规治疗中的效果比较
Pediatr Pulmonol. 1997 Jul;24(1):42-7. doi: 10.1002/(sici)1099-0496(199707)24:1<42::aid-ppul7>3.0.co;2-l.

引用本文的文献

1
Outcomes and Safety of Outpatient Parenteral Antimicrobial Therapy in Select Children with Cystic Fibrosis.部分囊性纤维化患儿门诊胃肠外抗菌治疗的疗效与安全性
Pediatr Allergy Immunol Pulmonol. 2019 Dec 1;32(4):149-154. doi: 10.1089/ped.2019.1073. Epub 2019 Dec 11.
2
Home intravenous antibiotic therapy in children with cystic fibrosis: clinical outcome, quality of life and economic benefit.囊性纤维化患儿的家庭静脉抗生素治疗:临床结局、生活质量和经济效益。
Hippokratia. 2016 Oct-Dec;20(4):279-283.
3
Clinical and cost-effectiveness, safety and acceptability of ommunity ntraenous ntibiotic ervice models: CIVAS systematic review.
社区静脉抗生素服务模式的临床及成本效益、安全性与可接受性:CIVAS系统评价
BMJ Open. 2017 Apr 20;7(4):e013560. doi: 10.1136/bmjopen-2016-013560.
4
Home versus hospital intravenous antibiotic therapy for cystic fibrosis.囊性纤维化患者家庭静脉注射抗生素治疗与医院静脉注射抗生素治疗的对比
Cochrane Database Syst Rev. 2015 Dec 15;2015(12):CD001917. doi: 10.1002/14651858.CD001917.pub4.
5
Physical activity in adults with cystic fibrosis receiving intravenous antibiotics in hospital and in the community.患有囊性纤维化的成年人在医院和社区接受静脉抗生素治疗期间的身体活动情况。
Open Respir Med J. 2015 Feb 25;9:15-21. doi: 10.2174/1874306401509010015. eCollection 2015.
6
A prospective cohort study of the use of domiciliary intravenous antibiotics in bronchiectasis.支气管扩张症患者家庭静脉用抗生素的前瞻性队列研究。
NPJ Prim Care Respir Med. 2014 Oct 23;24:14090. doi: 10.1038/npjpcrm.2014.90.
7
The cost effectiveness of dry powder antibiotics for the treatment of Pseudomonas aeruginosa in patients with cystic fibrosis.抗生素干粉剂治疗囊性纤维化患者铜绿假单胞菌感染的成本效果分析。
Pharmacoeconomics. 2014 Feb;32(2):159-72. doi: 10.1007/s40273-013-0122-x.
8
Continuous-infusion antipseudomonal Beta-lactam therapy in patients with cystic fibrosis.囊性纤维化患者的持续输注抗假单胞菌β-内酰胺治疗
P T. 2011 Nov;36(11):723-63.
9
Hospital versus home treatment of respiratory exacerbations in cystic fibrosis.囊性纤维化患者呼吸恶化的医院治疗与家庭治疗比较。
Med Sci Monit. 2011 Dec;17(12):CR698-703. doi: 10.12659/msm.882129.
10
Location and duration of treatment of cystic fibrosis respiratory exacerbations do not affect outcomes.囊性纤维化呼吸加重症的治疗位置和持续时间并不影响治疗结果。
Am J Respir Crit Care Med. 2010 Nov 1;182(9):1137-43. doi: 10.1164/rccm.201001-0057OC. Epub 2010 Jun 25.